Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot suit aims to steady aging and Parkinson's steps

NCT ID NCT07567482

Symptom relief Sponsor: Centre intégré de santé et de services sociaux de l'Outaouais Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a wearable robotic exoskeleton can improve walking, balance, and mobility in healthy older adults and people with Parkinson's disease—both groups at high risk for falls. About 26 participants will attend two lab sessions to try the device while performing tasks like walking and standing. Researchers will measure immediate effects and ask users about their experience to see if the exoskeleton is helpful and acceptable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 26 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participants with Parkinson's disease Inclusion Criteria: * Ability to walk for at least 30 minutes with or without minimal aid * Diagnosis of idiopathic Parkinson's disease * Hoehn and Yahr stage 1 to 4 Exclusion Criteria: * Height smaller than 152 cm * Severe vascular conditions of the lower limbs that may limit mobility or pose a risk. * Presence of any implantable or external life-sustaining medical device such as a pacemaker * Severe osteoporosis or high risk of fractures * Contra-indication to the required physical effort * Severe cognitive impairment (MoCA \< 21) * Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility, other than Parkinson's disease. Healthy elderly participants without Parkinson's disease Inclusion Criteria: * Ability to walk for at least 30 minutes with or without minimal aid * Age ≥ 65 years old Exclusion Criteria: * Height smaller than 152 cm * Severe vascular conditions of the lower limbs that may limit mobility or pose a risk. * Presence of any implantable or external life-sustaining medical device such as a pacemaker * Severe osteoporosis or high risk of fractures * Contra-indication to the required physical effort * Severe cognitive impairment (MoCA \< 21) * Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy aging Parkinson's disease (PD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • TechCare Research Lab - CISSS de l'Outaouais

    RECRUITING

    Gatineau, Quebec, J9H 3Z1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.